Find uplifting stories about heroes, innovations, and solutions
98 results for "** crispr"
A new FDA pathway could cut the time to get personalized CRISPR treatments from four years to just three months, making life-saving gene editing accessible to thousands of children born with rare genetic diseases. Baby KJ Muldoon became the first person to receive this revolutionary treatment in February 2025.
A Pennsylvania baby born with a deadly genetic disorder is now thriving after doctors created the world's first personalized CRISPR treatment just for him. Baby KJ can now eat protein and has stopped all medications after three doses of the groundbreaking therapy.
A Pennsylvania baby born with a deadly rare metabolic disorder is now thriving after doctors created the world's first personalized CRISPR gene therapy just for him. Six-month-old KJ can now eat protein and stopped all medications after three doses corrected his faulty gene.
A bacterial defense system discovered in 2012 has transformed into life-saving treatments for cancer and rare diseases. Scientists refined CRISPR gene editing from crude molecular scissors into precision medicine that's curing patients today.
Researchers programmed CRISPR technology to destroy cancer cells by targeting their unique genetic mutations, opening doors for treating previously "undruggable" cancers. This breakthrough could help millions of patients whose tumors resist current treatments.
Amjad Kazem Ahmed received Bahrain's first CRISPR gene therapy for sickle cell disease and is now sharing his journey through the challenging transition from illness to recovery. His story reveals the patience and determination required to reclaim a life once limited by disease.
Scientists in Israel used gene editing to remove the bitter taste from grapefruit, potentially opening the fruit to millions of new fans. The breakthrough could also save cold-weather citrus farming.
Scientists are using a safer twist on gene editing to treat diseases by flipping genetic switches instead of cutting DNA. The first trial results for a rare muscular disorder just arrived, and they're opening doors for conditions from high cholesterol to inherited diseases.
Scientists have flipped the script on aggressive cancers by using gene editing to turn one of their biggest advantages into a deadly vulnerability. In animal models, this breakthrough approach destroyed hard-to-treat tumors while leaving healthy cells unharmed.
Researchers created two new molecular tools that use everyday substances like caffeine and rapamycin to precisely control gene therapy, potentially making future cancer treatments safer and reversible. This breakthrough could allow doctors to fine-tune or halt treatments if side effects emerge.
Scientists have created a cancer-fighting technology that works like a smart weapon, identifying and destroying only the cells carrying specific cancer mutations while leaving healthy tissue untouched. Two new studies, including work from a Nobel laureate's lab, show the approach working in live animal models.
Melbourne researchers developed an AI tool that creates molecular "off switches" for CRISPR gene editing in just 8 weeks. The breakthrough could help make gene therapy treatments safer and more accessible for patients with genetic diseases.
Scientists from Harvard, MIT, and Case Western used CRISPR gene editing to extend the lives of mice with deadly prion diseases by 60%. While the treatment isn't ready for humans yet, it marks a breakthrough against diseases that currently have no cure.
)
A single gene-editing treatment could replace daily cholesterol pills for millions, after early trials showed one infusion cut dangerous LDL levels by 62% for up to 18 months. Scientists used CRISPR technology to modify how the body naturally clears cholesterol from blood.
Scientists at Utah State University discovered a CRISPR tool from cave bacteria that kills cancer cells while leaving healthy tissue untouched. Early tests in mice show it works by recognizing cancer's genetic signature from the inside out.
Children as young as 2 can now access a breakthrough gene therapy that could eliminate the need for lifelong blood transfusions. The FDA just expanded approval of Casgevy, a one-time CRISPR treatment that edits a patient's own cells to fight sickle cell disease.
Scientists have developed a one-time CRISPR treatment that fixes the genetic mutation causing the most common inherited kidney disease. Early tests show it could replace lifelong medication for 12 million people worldwide.
A single-dose CRISPR treatment freed patients from a painful genetic disorder that causes life-threatening swelling attacks. The breakthrough marks the first Phase 3 success for in vivo gene editing and could launch in 2027.
Children as young as 5 can now benefit from groundbreaking CRISPR gene therapy for severe blood disorders. New research shows the treatment works safely in younger kids, potentially preventing years of disease complications.
Researchers at Texas A&M have developed a way to control gene editing with caffeine, potentially allowing cancer and diabetes patients to activate treatment by drinking coffee. The breakthrough combines CRISPR technology with everyday compounds like caffeine and chocolate.
Showing 20 of 98